Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15
Rodman & Renshaw Initiates Coverage On Mural Oncology With Buy Rating, Announces Price Target of $15
罗德曼与仁信证券开始对Mural Oncology进行买入评级，并宣布价格目标为15美元。
Rodman & Renshaw analyst Tony Butler initiates coverage on Mural Oncology (NASDAQ:MURA) with a Buy rating and announces Price Target of $15.
Rodman＆Renshaw分析师Tony Butler开始对Mural Oncology（纳斯达克股票代码MURA）进行覆盖，评级为买入，并宣布目标价格为15美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间